| ORIGINAL ARTICLE |
|
| Year : 2022 | Volume
: 14
| Issue : 2 | Page : 149-153 |
|
|
Correlation of Vitamin D levels with markers of bone metabolism in COVID-19 patients
Alok Chandra Agrawal1, Ajoy Kumar Behera2, Eli Mohapatra3, Harshal Suhas Sakale1, Seema Shah3, Bikram Keshari Kar1, Mukund Madhav Ojha1, Buddhadeb Nayak1, Ankit Kumar Garg1
1 Department of Orthopaedics, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India
2 Department of Pulmonary Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India
3 Department of Biochemistry, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India
Correspondence Address:
Dr. Ankit Kumar Garg
D Block, Department of Orthopaedics, All India Institute of Medical Sciences, Tatibandh, Raipur - 492 099, Chhattisgarh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jotr.jotr_115_22
|
|
|
Introduction: Low serum Vitamin D levels are common in orthopedic patients in India. Low serum Vitamin D levels are implicated in COVID-19 worsening the illness. With this background, we assessed serum Vitamin D levels in COVID-19 patients presenting to us and correlated them with other markers of bone metabolism and systemic immune response. Materials and Methods: A cross-sectional analytical study was done on 107 COVID-19 patients. The sample was taken for serum calcium, serum Vitamin D, serum phosphate, bone-specific alkaline phosphatase (ALP), serum parathyroid hormone, creatine phosphokinase (CPK), CPK myocardial band (MB), serum protein, C-reactive protein, erythrocyte sedimentation rate, and hemoglobin in these patients. The levels were correlated with each other to assess their relations in COVID-19 patients. Results: One hundred out of 107 patients had low serum Vitamin D levels. In these patients, serum lactate dehydrogenase and serum ALP levels were high, and creatine kinase MB levels were low. The illness was found more in diabetic/hypertensive and rheumatoid arthritis patients. The values and findings correlate with increased disease activity and osteopenia with no obvious muscular injury. Conclusion: Managing Vitamin D deficiency (VDD) has been taken up as a major step in COVID-19 affection. The markers of bone metabolism and their correlation with serum Vitamin D were equivocal in COVID-19-affected and not affected Indian populations. The risk of infection has been more in diabetic, hypertensive, and rheumatoid arthritis patients, all of whom were also suffering from VDD.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
